Table 3.

Association between liver enzymes and pre-hypertension among study groups

Pre-hypertension
	OR (95%CI)	P value	Adjusted OR (95%CI)	P value
AST
1st (≤ 18)	Reference		Reference
2nd (19–23)	1.35(1.14–1.61)	0.001	1.24(1.04–1.48)	0.016
3rd (≥ 24)	1.17(0.98–1.41)	0.080	1.08(0.89–1.31)	0.413
ALT
1st (≤ 18)	Reference		Reference
2nd (19–26)	1.38(1.16–1.65)	< 0.001	1.19(0.99–1.43)	0.057
3rd (≥ 27)	1.45(1.21–1.74)	< 0.001	1.34(1.09–1.63)	0.004
ALP
1st (≤ 160)	Reference		Reference
2nd (161–206)	1.28(1.07–1.53)	0.007	1.08(0.90–1.31)	0.367
3rd (≥ 207)	1.50(1.25–1.79)	< 0.001	1.05(0.87–1.27)	0.57
GGT
1st (≤ 16)	Reference		Reference
2nd (17–25)	1.09(0.91–1.31)	0.334	0.92(0.76–1.12)	0.438
3rd (≥ 26)	1.56(1.31–1.86)	< 0.001	1.25(1.03–1.52)	0.024

Adjusted for age, gender, WSI (socioeconomic status), Physical Activity (MET), BMI, waist circumference, diabetes, prediabetes

Aspartate aminotransferase, ALT: Alanine aminotransferase, GGT: Gamma-glutamyl transferase, ALP: Alkaline phosphatase